| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,441 |
10,716 |
$1.58M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,706 |
1,403 |
$140K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,078 |
962 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,575 |
1,179 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
894 |
382 |
$34K |
| 80053 |
Comprehensive metabolic panel |
3,764 |
3,308 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,483 |
3,064 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
6,129 |
5,086 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
692 |
625 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
428 |
381 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
660 |
618 |
$9K |
| 84481 |
|
681 |
621 |
$8K |
| 99215 |
Prolong outpt/office vis |
89 |
58 |
$7K |
| 80061 |
Lipid panel |
591 |
525 |
$7K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
157 |
36 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
110 |
92 |
$5K |
| 84436 |
|
871 |
811 |
$5K |
| 87070 |
|
617 |
551 |
$5K |
| 84479 |
|
857 |
796 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
98 |
79 |
$4K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
17 |
12 |
$2K |
| 81003 |
|
1,434 |
1,249 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
128 |
25 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
31 |
28 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
90 |
76 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
148 |
135 |
$1K |
| 84484 |
|
105 |
89 |
$878.03 |
| 82553 |
|
89 |
77 |
$481.66 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
27 |
24 |
$475.00 |
| 82550 |
|
112 |
101 |
$374.54 |
| 84439 |
|
59 |
48 |
$333.74 |
| 81025 |
|
29 |
25 |
$230.13 |
| 83880 |
|
17 |
14 |
$196.30 |
| 85027 |
|
15 |
12 |
$74.20 |
| 85007 |
|
15 |
12 |
$34.10 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
24 |
12 |
$33.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
17 |
12 |
$0.03 |
| 90791 |
Psychiatric diagnostic evaluation |
50 |
48 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
20,321 |
820 |
$0.00 |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
5,039 |
283 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
161 |
110 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
32 |
27 |
$0.00 |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
10,757 |
297 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
14 |
13 |
$0.00 |
| 05983 |
|
25 |
14 |
$0.00 |